BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24216)

  • 1. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
    Schrader WP; Pollara B; Meuwissen HJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
    Daddona PE; Kelley WN
    Biochim Biophys Acta; 1981 Apr; 658(2):280-90. PubMed ID: 6972784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency.
    Ratech H; Hirschhorn R
    Clin Chim Acta; 1981 Sep; 115(3):341-7. PubMed ID: 6975191
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
    Hirschhorn R; Beratis N; Rosen FS
    Proc Natl Acad Sci U S A; 1976 Jan; 73(1):213-7. PubMed ID: 1061119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of adenosine deaminating activity in normal and adenosine deaminase deficient human tissue.
    Van der Weyden MB; Jack I; Ziegler JB
    Adv Exp Med Biol; 1984; 165 Pt B():67-70. PubMed ID: 6609541
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of adenosine deaminase deficiency in the mutant mouse wasted.
    Geiger JD; Nagy JI
    FEBS Lett; 1986 Nov; 208(2):431-4. PubMed ID: 3780980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
    Lin AL; Elford HL
    J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunoassay of adenosine deaminase in combined immunodeficiency disease.
    Carson DA; Goldblum R; Seegmiller JE
    J Immunol; 1977 Jan; 118(1):270-3. PubMed ID: 830750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase and immunodeficiency: an in vitro model.
    Hirschhorn R; Sela E
    Cell Immunol; 1977 Aug; 32(2):350-60. PubMed ID: 902324
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.
    Hirschhorn R; Martiniuk F; Rosen FS
    Clin Immunol Immunopathol; 1978 Mar; 9(3):287-92. PubMed ID: 627115
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiency of adenosine deaminase in the wasted mouse.
    Abbott CM; Skidmore CJ; Searle AG; Peters J
    Proc Natl Acad Sci U S A; 1986 Feb; 83(3):693-5. PubMed ID: 3456164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase activity in recipients of bone marrow from immunodeficient mice homozygous for the wasted mutation.
    Willis EH; Carson DA; Shultz LD
    Biochem Biophys Res Commun; 1987 May; 145(1):581-5. PubMed ID: 3297058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase and nucleoside phosphorylase activity in patients with immunodeficiency syndromes.
    Chen SH; Ochs HD; Scott CR; Giblett ER
    Clin Immunol Immunopathol; 1979 Jun; 13(2):156-60. PubMed ID: 110506
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison and possible homology of isozymes of adenosine deaminase in Aves and humans.
    Ratech H; Thorbecke GJ; Meredith G; Hirschhorn R
    Enzyme; 1981; 26(2):74-84. PubMed ID: 7238474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine metabolism in adenosine deaminase deficiency.
    Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.